Cargando…
Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Autores principales: | Meroni, Pier Luigi, Tsokos, George C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398508/ https://www.ncbi.nlm.nih.gov/pubmed/30858846 http://dx.doi.org/10.3389/fimmu.2019.00199 |
Ejemplares similares
-
Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Gerosa, Maria, et al.
Publicado: (2016) -
Neutrophils—Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Wirestam, Lina, et al.
Publicado: (2019) -
Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus
por: Mizui, Masayuki, et al.
Publicado: (2018) -
Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus
por: Katsuyama, Takayuki, et al.
Publicado: (2018) -
Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)
por: Savelli, Stephanie L., et al.
Publicado: (2019)